Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis

被引：0
|
作者：
Dalal, Rahul S. [1 ]
Clarke, Lindsay M. [1 ]
Carlin, Alex [1 ]
Cabral, Heidy [1 ]
Allegretti, Jessica R. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2024年
关键词：
ulcerative colitis; inflammatory bowel disease; biologics; bio-na & iuml; ve; INFLAMMATORY-BOWEL-DISEASE;
D O I：
10.1093/ibd/izae215
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In this retrospective cohort study, vedolizumab was associated with higher odds of steroid-free clinical remission at 1 year compared to anti-TNF agents for bio-na & iuml;ve patients with ulcerative proctitis.
引用
收藏
页码：1174 / 1177
页数：4
相关论文
共 50 条
  • [1] Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review
    Irving, Peter M.
    Hur, Peter
    Gautam, Raju
    Guo, Xiang
    Vermeire, Severine
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (09) : 1026 - 1040
  • [2] A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for pediatric Crohn's disease
    Manuel Navas-Lopez, Victor
    Pujol Muncunill, Gemma
    Llerena, Enrique
    Naval Rubio, Maria
    Gil-Ortega, David
    Varea-Calderon, Vicente
    Sierra Salinas, Carlos
    Martin-de-Carpi, Javier
    ANALES DE PEDIATRIA, 2018, 88 (02): : 89 - 99
  • [3] Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States
    Long, Millie D.
    Smith, Timothy W.
    Dibonaventura, Marco
    Gruben, David
    Bargo, Danielle
    Salese, Leonardo
    Quirk, Daniel
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (06) : 941 - 948
  • [4] Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis
    Makoto Naganuma
    Taku Kobayashi
    Reiko Kunisaki
    Katsuyoshi Matsuoka
    Shojiro Yamamoto
    Ami Kawamoto
    Daisuke Saito
    Kosaku Nanki
    Kazuyuki Narimatsu
    Hisashi Shiga
    Motohiro Esaki
    Shinichiro Yoshioka
    Shingo Kato
    Masayuki Saruta
    Shinji Tanaka
    Eriko Yasutomi
    Kaoru Yokoyama
    Kei Moriya
    Yoshikazu Tsuzuki
    Makoto Ooi
    Mikihiro Fujiya
    Atsushi Nakazawa
    Takayuki Abe
    Tadakazu Hisamatsu
    Journal of Gastroenterology, 2023, 58 : 1198 - 1210
  • [5] Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis
    Naganuma, Makoto
    Kobayashi, Taku
    Kunisaki, Reiko
    Matsuoka, Katsuyoshi
    Yamamoto, Shojiro
    Kawamoto, Ami
    Saito, Daisuke
    Nanki, Kosaku
    Narimatsu, Kazuyuki
    Shiga, Hisashi
    Esaki, Motohiro
    Yoshioka, Shinichiro
    Kato, Shingo
    Saruta, Masayuki
    Tanaka, Shinji
    Yasutomi, Eriko
    Yokoyama, Kaoru
    Moriya, Kei
    Tsuzuki, Yoshikazu
    Ooi, Makoto
    Fujiya, Mikihiro
    Nakazawa, Atsushi
    Abe, Takayuki
    Hisamatsu, Tadakazu
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (12) : 1198 - 1210
  • [6] Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis
    Kojima, Kentaro
    Watanabe, Kenji
    Kawai, Mikio
    Yagi, Soichi
    Kaku, Koji
    Ikenouchi, Maiko
    Sato, Toshiyuki
    Kamikozuru, Koji
    Yokoyama, Yoko
    Takagawa, Tetsuya
    Shimizu, Masahito
    Shinzaki, Shinichiro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (13) : 1871 - 1886
  • [7] Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis
    Gros, Beatriz
    Goodall, Mairi
    Plevris, Nik
    Constantine-Cooke, Nathan
    Elford, Alexander T.
    O'Hare, Claire
    Noble, Colin
    Jones, Gareth-Rhys
    Arnott, Ian D.
    Lees, Charlie W.
    JOURNAL OF CROHNS & COLITIS, 2023,
  • [8] Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
    Chaparro, Maria
    Garre, Ana
    Iborra, Marisa
    Sierra-Ausin, Monica
    Barreiro-de Acosta, Manuel
    Fernandez-Clotet, Agnes
    de Castro, Luisa
    Bosca-Watts, Maia
    Jose Casanova, Maria
    Lopez-Garcia, Alicia
    Lorente, Rufo
    Rodriguez, Cristina
    Carbajo, Ana Y.
    Teresa Arroyo, Maria
    Gutierrez, Ana
    Hinojosa, Joaquin
    Martinez-Perez, Teresa
    Villoria, Albert
    Bermejo, Fernando
    Busquets, David
    Camps, Blau
    Canete, Fiorella
    Mancenido, Noemi
    Monfort, David
    Navarro-Llavat, Merce
    Lazaro Perez-Calle, Jose
    Ramos, Laura
    Rivero, Montserrat
    Angueira, Teresa
    Camo Monterde, Patricia
    Carpio, Daniel
    Garcia-de-la-Filia, Irene
    Gonzalez-Munoza, Carlos
    Hernandez, Luis
    Huguet, Jose M.
    Morales, Victor J.
    Sicilia, Beatriz
    Vega, Pablo
    Vera, Isabel
    Zabana, Yamile
    Nos, Pilar
    Suarez Alvarez, Patricia
    Calvino-Suarez, Cristina
    Ricart, Elena
    Hernandez, Vicent
    Minguez, Miguel
    Marquez, Lucia
    Hervias Cruz, Daniel
    Rubio Iturria, Saioa
    Barrio, Jesus
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (11) : 1846 - 1851
  • [9] Real-World Patterns and Economic Burden Associated With Treatment Failure With Advanced Therapies in Patients With Moderate-to-Severe Ulcerative Colitis
    Lee, Scott D.
    Betts, Keith A.
    Du, Ella Xiaoyan
    Nie, Xiaoyu
    Gupte-Singh, Komal
    Ritter, Timothy
    CROHNS & COLITIS 360, 2024, 6 (02)
  • [10] Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study
    Nogami, Akira
    Asonuma, Kunio
    Okabayashi, Shinji
    Ikenouchi, Maiko
    Matsuda, Takahisa
    Shinzaki, Shinichiro
    Fukata, Masayuki
    Kobayashi, Taku
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, : 1357 - 1366
12345